Sartorius Stedim Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Sartorius Stedim Biotech has a total shareholder equity of €2.7B and total debt of €3.6B, which brings its debt-to-equity ratio to 133.5%. Its total assets and total liabilities are €7.7B and €5.1B respectively. Sartorius Stedim Biotech's EBIT is €468.7M making its interest coverage ratio 4.3. It has cash and short-term investments of €126.1M.
Key information
133.5%
Debt to equity ratio
€3.57b
Debt
| Interest coverage ratio | 4.3x |
| Cash | €126.10m |
| Equity | €2.67b |
| Total liabilities | €5.07b |
| Total assets | €7.74b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DIM N's short term assets (€1.4B) exceed its short term liabilities (€937.3M).
Long Term Liabilities: DIM N's short term assets (€1.4B) do not cover its long term liabilities (€4.1B).
Debt to Equity History and Analysis
Debt Level: DIM N's net debt to equity ratio (128.7%) is considered high.
Reducing Debt: DIM N's debt to equity ratio has increased from 12.7% to 133.5% over the past 5 years.
Debt Coverage: DIM N's debt is well covered by operating cash flow (20.9%).
Interest Coverage: DIM N's interest payments on its debt are well covered by EBIT (4.3x coverage).